Proton Power Systems acquires SPower Holding GmbH

Proton Power Systems has agreed to acquire SPower Holding GmbH and its subsidiary SPower GmbH for 5.0m euros.

Proton Power Systems has agreed to acquire SPower Holding GmbH and its subsidiary SPower GmbH for 5.0m euros.

The company, which designs and produces hydrogen fuel cells and hydrogen fuel cell electric hybrid systems, said it will merge SPower with its subsidiary Proton Motor Fuel Cell GmbH.

The newly merged company will continue to operate under the name of Proton Motor Fuel Cell GmbH.

SPower's products will be sold under a product line called SPower within Proton Motor.

SPower was formed in 2007 and supplies power solutions to IT, Telecoms, public infrastructure and healthcare customers in Germany, Europe and Middle East.

It also supplies solar systems and has a new product line called Solar Energy Storage, which will be released to the market in the second quarter of 2013.

The group is expected to report a turnover of circa €3.0m and to break even in operating profits for last year.

The integration of the SPower is anticipated to result in cost synergies of about €200,000 per annum, but to increase turnover to €5.0m.

"The acquisition of SPower allows Proton Power to enlarge its offering for stationary power solutions," Chief Executive of Proton Power, Dr. Faiz Nahab, said.

"As a company, we can importantly offer complete systems to our customers. The new battery storage solution of SPower for solar systems will have an extremely positive impact on our business. The process optimisation and cost savings will also have positive effects and will enhance value for our shareholders."

RD

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

Barry Norris: we’re already in the 1970s. Here’s how to invest
Investment strategy

Barry Norris: we’re already in the 1970s. Here’s how to invest

Merryn talks to Barry Norris of Argonaut capital about the parallels between now and the 1970s; the transition to “green” energy; and the one sector w…
19 May 2022
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022